Compare ZURA & BTBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZURA | BTBT |
|---|---|---|
| Founded | 2022 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.4M | 427.6M |
| IPO Year | 2021 | 2017 |
| Metric | ZURA | BTBT |
|---|---|---|
| Price | $0.97 | $0.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $8.00 | $3.25 |
| AVG Volume (30 Days) | 6.7M | ★ 22.7M |
| Earning Date | 10-27-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $113,560,320.00 |
| Revenue This Year | N/A | $14.71 |
| Revenue Next Year | N/A | $176.59 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 5.10 |
| 52 Week Low | $0.92 | $0.58 |
| 52 Week High | $7.25 | $2.48 |
| Indicator | ZURA | BTBT |
|---|---|---|
| Relative Strength Index (RSI) | 24.64 | 27.19 |
| Support Level | $0.93 | N/A |
| Resistance Level | $5.97 | $1.75 |
| Average True Range (ATR) | 0.23 | 0.08 |
| MACD | -0.15 | 0.00 |
| Stochastic Oscillator | 0.46 | 0.78 |
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.